LDLR Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of LDLR monoclonal antibodies for various research applications. LDLR monoclonal antibodies are optimized for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Low-Density Lipoprotein Receptor (LDLR) plays a critical role in lipid metabolism by mediating the endocytosis of cholesterol-rich lipoproteins, thereby regulating cholesterol levels in the bloodstream. Dysregulation of LDLR function is associated with hypercholesterolemia and cardiovascular diseases, making it a significant target for therapeutic interventions. Understanding LDLR's role in cellular processes is essential for advancing research in lipid metabolism and related disorders. LDLR monoclonal antibodies enable researchers to investigate cellular uptake mechanisms and track protein expression patterns across different tissue types. Studying LDLR activity provides insights into cholesterol homeostasis and potential therapeutic strategies for cardiovascular conditions. LDLR research using Santa Cruz Biotechnology monoclonal antibodies continues to advance our understanding of lipid metabolism and cardiovascular health, supporting breakthrough discoveries in the scientific community.